Inimmune
Blood & Organ Banks · Montana, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1121 E Broadway St Ste 106, Missoula, Mo...Phone Number
(406) 541-5913Website
www.inimmune.comRevenue
$5.2 MillionIndustry
About Inimmune
Inimmune is a clinical-stage biotech company focused on developing innovative immunotherapeutics to address major unmet medical needs in inflammatory conditions, including cancer, food allergies, and autoimmune diseases. Their pipeline includes advanced immunotherapies such as INI-4001 and INI-2004, which are currently in clinical trials for various applications. Inimmune also specializes in creating vaccine adjuvants and collaborates with leading universities and biotech firms to enhance their research and development efforts. The company aims to harness the innate immune system to drive significant improvements in human health.Explore more
Inimmune Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Inimmune
Compare insights from companies similar to Inimmune, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Inimmune Tech Stack
A closer look at the technologies used by Inimmune
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Inimmune
Sign Up For FreeTo access detailed company insights
Inimmune is a clinical-stage biotech company focused on developing innovative immunotherapeutics to address major unmet medical needs in inflammatory conditions, including cancer, food allergies, and autoimmune diseases. Their pipeline includes advanced immunotherapies such as INI-4001 and INI-2004, which are currently in clinical trials for variou... Read More
